Patient characteristics
| Characteristics . | n . | B7-H3 (MFI) . | P value . |
|---|---|---|---|
| Mean ± SD . | |||
| Sex | |||
| Female | 40 | 3985 ± 2346 | .21 |
| Male | 60 | 3488 ± 1594 | |
| AML subtype | |||
| M0 | 10 | 3665 ± 3506 | .09 |
| M1 | 45 | 3842 ± 1379 | |
| M2 | 28 | 3549 ± 1867 | |
| Others | 17 | 3512 ± 2235 | |
| Treatment | |||
| No | 34 | 3322 ± 1528 | .17 |
| Yes | 66 | 3874 ± 2100 | |
| ELN score | |||
| Good | 15 | 2927 ± 962 | .02 |
| Intermediate | 18 | 2798 ± 1059 | |
| Poor | 68 | 4095 ± 2148 | |
| Death | |||
| No | 24 | 3351 ± 1640 | .04 |
| Yes | 35 | 4494 ± 2432 | |
| Relapse | |||
| No | 43 | 4087 ± 2323 | .88 |
| Yes | 16 | 3873 ± 1903 |
| Characteristics . | n . | B7-H3 (MFI) . | P value . |
|---|---|---|---|
| Mean ± SD . | |||
| Sex | |||
| Female | 40 | 3985 ± 2346 | .21 |
| Male | 60 | 3488 ± 1594 | |
| AML subtype | |||
| M0 | 10 | 3665 ± 3506 | .09 |
| M1 | 45 | 3842 ± 1379 | |
| M2 | 28 | 3549 ± 1867 | |
| Others | 17 | 3512 ± 2235 | |
| Treatment | |||
| No | 34 | 3322 ± 1528 | .17 |
| Yes | 66 | 3874 ± 2100 | |
| ELN score | |||
| Good | 15 | 2927 ± 962 | .02 |
| Intermediate | 18 | 2798 ± 1059 | |
| Poor | 68 | 4095 ± 2148 | |
| Death | |||
| No | 24 | 3351 ± 1640 | .04 |
| Yes | 35 | 4494 ± 2432 | |
| Relapse | |||
| No | 43 | 4087 ± 2323 | .88 |
| Yes | 16 | 3873 ± 1903 |
ELN, European LeukemiaNet; MFI, mean fluorescence intensity.